Spermicides, microbicides and antiviral agents: Recent advances in the development of novel multi-functional compounds

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 13, 2009, Pages 1556-1567

  Baptista, Marta ^a   Ramalho Santos, João ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Antiretroviral agents; Contraception; Female reproductive tract; HIV infection; Microbicides; Sperm; Spermicides

Indexed keywords

ALCOHOL; ANTIVIRUS AGENT; BUFFER; CONTRACEPTIVE AGENT; DAPIVIRINE; MICROBICIDE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; NONIONIC SURFACTANT; NONOXINOL 9; PRO 2000; SPERMICIDAL AGENT; TENOFOVIR; VIVAGEL;

CLINICAL TRIAL; CONDOM; CONTRACEPTION; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SALPINGECTOMY; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; UNWANTED PREGNANCY; VASECTOMY; VIRUS REPLICATION;

ANTI-INFECTIVE AGENTS; ANTIVIRAL AGENTS; FEMALE; HUMANS; SEXUALLY TRANSMITTED DISEASES; SPERMATOCIDAL AGENTS;

EID: 75449084546     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709790361548     Document Type: Short Survey

References (126)

1. Gayle, H. An overview of the global HIV/AIDS epidemic, with a focus on the United States. AIDS, 2000, 14 (Supl 2), 8-17.
2. Jain, R.K.; Jain, A.; Maikhuri, J.P.; Sharma, V.L.; Dwivedi, A.K.; Kumar, S.T.; Mitra, K.; Bajpai, V.K.; Gupta, G. In vitro testing of rationally designed spermicides for selectively targeting human sperm in vagina to ensure safe contraception. Hum. Reprod., 2009, 24, 590-601.
3. Munch, J.; Rucker, E.; Standker, L.; Adermann, K.; Goffinet, C.; Schindler, M.; Wildum, S.; Chinnadurai, R.; Rajan, D.; Specht, A.; Gimenez-Gallego, G.; Sanchez, P.C.; Fowler, D.M.; Koulov, A.; Kelly, J.W.; Mothes, W.; Grivel, J.C.; Margolis, L.; Keppler, O.T.; Forssmann, W.G.; Kirchhoff, F. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell, 2007, 131, 1059-71.
4. Cohen, M.S.; Kashuba, A.D.M. Antiretroviral therapy for prevention of HIV infection: new clues from an animal model. PLoS Med., 2008, 5, 190-92.
5. Fichorova, R.N.; Tucker, L.D.; Anderson, D.J. The molecular basis of nonoxynol-9 - induced vaginal inflammation and its possible relevance to Human Immunodeficiency Virus type 1 transmission. J. Infect. Dis., 2001, 184, 418-28.
6. UNAIDS, WHO. AIDS epidemic update 2007. Available at http://www.unaids.org.
7. Fauci, A.S. Twenty-five years of HIV/AIDS. Science, 2006, 313, 409.
8. Saracco, A.; Musicco, M.; Nicolosi, A.; Angarano, G.; Arici, C.; Gavazzeni, G.; Costigliola, P.; Gafa, S.; Gervasoni, C.; Luzzati, R.; Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J. Acquir. Immune Defic. Syndr., 1993, 5, 497-502.
9. Aitken, R.J.; Baker, M.A.; Doncel, G.F.; Matzuk, M.M.; Mauck, C.K.; Harper, M.J.K. As the world grows: contraception in the 21st century. J. Clin. Invest., 2008, 118, 1330-43.
10. Sitruk-Ware, R. Contraception: an international perspective. Contraception, 2006, 73, 215-22.
11. Doncel, G.F. Exploiting common targets in human fertilization and HIV infection: development of novel contraceptive microbicides. Hum. Reprod. Update., 2006, 12, 103-17.
12. Moscicki, A.B. Vaginal microbicides: where are we and where are we going? J. Infect. Chemother., 2008, 14, 337-41.
13. CDC, Centers for Disease Control and Prevention. HIV and its transmission. Department of Health and Human Services. 1999. Available at http://www.cdc.gov/hiv.
14. Gaym, A. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention. Ethiop. Med. J., 2006, 44, 405-15.
15. Turner, B.G.; Summers, M.F. Structural biology of HIV. J. Mol. Biol., 1999, 285, 1-32.
16. Wyatt, R.; Sodroski, J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science, 1998, 280, 1884-88.
17. Pierson, T.C.; Doms, R.W. HIV-1 entry and its inhibition. Curr. Top. Microbiol. Immunol., 2003, 281, 1-27.
18. Miller, C.J.; Shattock, R.J. Target cells in vaginal HIV transmission. Microbes Infect., 2003, 5, 59-67.
19. McGowan, I. Microbicides: A new frontier in HIV prevention. Biologicals, 2006, 34, 241-55.
20. Corey, L.; Wald, A.; Celum, C.L.; Quinn, T.C. The effects of Herpes Simplex Virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr., 2004, 35, 435-45.
21. Wilkinson, D.; Abdool Karim, S.S.; Harrison, A.; Lurie, M.; Colvin, M.; Connolly, C.; Sturm, A.W. Unrecognised sexually transmitted infections in rural South African women: a hidden epidemic. Bull World Health Organ., 1999, 77, 22-28.
22. Elias, C.J.; Coggins, C. Female-controlled methods to prevent sexual transmission of HIV. AIDS, 1996, 3, 43-51.
23. Balzarini, J.; Van Damme, L. Microbicide drug candidates to prevent HIV infection. Lancet, 2007, 369, 787-97.
24. Dhawan, D.; Mayer, K.H. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection. J. Infect. Dis., 2006, 193, 36-44.
25. Global Health Council. Women's health. 2008. Available at http://www.globalhealth.org/view-top.php3?id=225.
26. Kumar, T.C.A. The value and use of different contraceptive methods. Hum. Reprod., 1994, 9, 578-85.
27. Lech, M.M. Spermicides 2002: an overview. Eur. J. Contracept. Reprod. Health Care, 2002, 7, 173-7.
28. Lee, C.H. Review: In vitro spermicidal tests. Contraception, 1996, 54, 131-47.
29. Sander, F.V.; Cramer, S.D. Practical method for testing the spermicidal action of chemical contraceptives. Hum. Fertil., 1941, 6, 134-37.
30. Jeyendran, R.S.; Van der Ven, H.H.; Perez-Pelaez, M.; Diedrich, K.; Zaneveld, L.J. Development of an assay to assess the functional integrity of the human sperm membranes and its relationship to other semen characteristics. J. Reprod. Fertil., 1984, 70, 219-28.
31. Yanagimachi, R.; Yanagimachi, H.; Rogers, B.J. The use of zonafree animal ova as a test-system for the assessment of the fertilizing capacity of human spermatozoa. Biol. Reprod., 1976, 15, 471-76.
32. Björndahl, L.; Söderlund, I.; Kvist, U. Evaluation of the one-step eosin-nigrosin staining technique for human sperm vitality assessment. Hum. Reprod., 2003, 18, 813-16.
33. Garner, D.L.; Johnson, L.A. Viability Assessment of Mammalian Sperm Using SYBR-14 and Propidium Iodide. Biol. Reprod., 1995, 53, 276-84.
34. Chalah, T.; Brillard, J.P. Comparison of assessment of fowl sperm viability by eosin-nigrosin and dual fluorescence (SYBR-14/PI). Theriogenology, 1998, 50, 487-93.
35. Ramalho-Santos, J.; Amaral, A.; Sousa, A.P.; Rodrigues, A.S.; Martins, L.; Baptista, M.; Mota, P.C.; Tavares, R.; Amaral, S.; Gamboa, S. In Modern Research and Educational Topics in Microscopy; Méndez-Vilas, A.; Díaz, J.; Eds. Extremadura: FORMATEX, 2007; Vol. 1, pp. 394-402.
36. Hughes, L.M.; Griffith, R.; Aitken, R.J. The search for a topical dual action spermicide/microbicide. Curr. Med. Chem., 2007, 14, 775-86.
37. D'Cruz, O.J.; Zhu, Z.; Yiv, S.H.; Chen, C L.; Waurzyniak, B.; Uckun, F.M. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity. Contraception, 1999, 59, 319-31.
38. D'Cruz, O.J.; Waurzyniak, B.; Uckun, F.M. Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats. Antimicrob. Agents Chemother., 2004, 48, 1082-88.
39. Wong, Y.L.; Hubieki, M.P.; Curfman, C.L.; Doncel, G.F.; Dudding, T.C.; Savle, P.S.; Gandour, R.D. A structure-activity study of spermicidal and anti- HIV properties of hydroxylated cationic surfactants. Bioorg. Med. Chem., 2002, 10, 3599-608.
40. Hillier, S.L.; Moench, T.; Shattock, R.; Black, R.; Reichelderfer, P.; Veronese, F. In vitro and in vivo: the story of nonoxynol 9. J.Acquir. Immune Defic. Syndr., 2005, 39, 1-8.
41. Cross, N.L. Effect of methyl-beta-cyclodextrin on the acrosomal responsiveness of human sperm. Mol. Reprod. Dev., 1999, 53, 92-98.
42. Liao, Z.; Cimakasky, L.M.; Hampton, R.; Nguyen, D.H.; Hildreth, J.E. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses, 2001, 17, 1009-19.
43. Simons, K.; Ikonen, E. Functional rafts in cell membranes. Nature, 1997, 387, 569-72.
44. Ramalho-Santos, J.; Moreno, R.D.; Sutovsky, P.; Chan, A.W.; Hewitson, L.; Wessel, G.M.; Simerly, C.R.; Schatten, G. SNAREs in mammalian sperm: possible implications for fertilization. Dev.Biol., 2000, 223, 54-69.
45. Parinaud, J.; Vieitez, G.; Vieu, C.; Collet, X.; Perret, B. Enhancement of zona binding using 2-hydroxypropyl- beta cyclodextrin. Hum. Reprod., 2000, 15, 1117-120.
46. Campbell, S.M.; Crowe, S.M.; Mak, J. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol., 2001, 22, 217-27.
47. Graham, D.R.; Chertova, E.; Hilburn, J.M.; Arthur, L.O.; Hildreth, J.E. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion associated lipid rafts. J. Virol., 2003, 77, 8237-248.
48. Chaki, S.P.; Misro, M M. Assessment of human sperm function after hydrogen peroxide exposure: development of a vaginal contraceptive. Contraception, 2002, 66, 187-192.
49. Klebanoff, S.J.; Coombs, R.W. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J. Exp. Med., 1991, 174, 289-92.
50. Cohen, F.S.; Melikyan, G.B. The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J. Membr. Biol., 2004, 199, 1-14.
51. Primakoff, P.; Myles, D.G. Cell-cell membrane fusion during mammalian fertilization. FEBS Lett., 2007, 581, 2174-180.
52. Kensinger, R.D.; Catalone, B.J.; Krebs, F.C.; Wigdahl, B.; Schengrund, C.L. Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrob. Agents Chemother., 2004, 48, 1614-23.
53. Oehninger, S.; Clark, G.F.; Acosta, A.A.; Hodgen, G.D. Nature of the inhibitory effect of complex saccharide moieties on the tight binding of human spermatozoa to the human zona pellucida. Fertil. Steril., 1991, 55, 165-69.
54. Anderson, R.A.; Feathergill, K.A.; Diao, X.H.; Cooper, M.D.; Kirkpatrick, R.; Herold, B.C.; Doncel, G.F.; Chany, C.J.; Waller, D.P.; Rencher, W.F. Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent. J. Androl., 2002, 23, 426-38.
55. U.S. National Library of Medicine. National Institutes of Health, Health and Human Services, Rockville Pike, Bethesda, MD, USA, 2009. Available at www.clinicaltrials.gov.
56. Alliance for Microbicide Development. February 2009 Pipeline Update. Silver Spring, MD, USA, 2009. Available at www.microbicide.org.
57. Helenius, A.; Simons, K. Solubilization of membranes by detergents. Biochim. Biophys. Acta, 1975, 415, 29-79.
58. le Maire, M.; Champeil, P.; Moller, J.V. Interaction of membrane proteins and lipids with solubilizing detergents. Biochim. Biophys. Acta, 2000, 1508, 86-111.
59. Vieira, D.B.; Carmona-Ribeiro, A.M. Cationic lipids and surfactants as antifungal agents: mode of action. J. Antimicrob. Chemother., 2006, 58, 760-67.
60. Patrzykat, A.; Friedrich, C.L.; Zhang, L.; Mendoza, V.; Hancock, R.E.W. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother., 2002, 46, 605-14.
61. Sampaio, J.L.; Moreno, M.J.; Vaz, W.L. Kinetics and thermodynamics of association of a fluorescent lysophospholipid derivative with lipid bilayers in liquid-ordered and liquid disordered phases. Biophys. J., 2005, 88, 4064-71.
62. Strupp, W.; Weidinger, G.; Scheller, C.; Ehret, R.; Ohnimus, H.; Girschick, H.; Tas, P.; Flory, E.; Heinkelein, M.; Jassoy, C. Treatment of cells with detergent activates caspases and induces apoptotic cell death. J. Membr. Biol., 2000, 175, 181-89.
63. Dias, R.S.; Innerlohinger, J.; Glatter, O.; Miguel, M.G.; Lindman, B. Coil-globule transition of DNA molecules induced by cationic surfactants: A dynamic light scattering study. J. Phys. Chem., 2005, 109, 10458-463.
64. Dietrich, G.J.; Zabowska, M.; Wojtczak, M.; Słowińska, M.; Kucharczyk, D.; Ciereszko, A. Effects of different surfactants on motility and DNA integrity of brown trout (Salmo trutta fario) and common carp (Cyprinus carpio) spermatozoa. Reprod. Biol., 2007, 7, 127-42.
65. Vock, E.H.; Lutz, W.K.; Hormes, P.; Hoffmann, H.D.; Vamvakas, S. Discrimination between genotoxicity and cytotoxicity in the induction of DNA double-strand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide, Triton X-100, and gamma-irradiation. Mutat. Res., 1998, 413, 83-94.
66. Cutler, B.; Justman, J. Vaginal microbicides and the prevention of HIV transmission. Lancet Infect. Dis., 2008, 8, 685-97.
67. White, D.R.; Clarkson, J.S.; Ratnasooriya, W.D.; Aitken, R.J. Complementary effects of propranolol and Nonoxynol-9 upon human sperm motility. Contraception, 1995, 52, 241-47.
68. Van Damme, L.; Ramjee, G.; Alary, M.; Vuylsteke, B.; Chandeying, V.; Rees, H.; Sirivongrangson, P.; Mukenge-Tshibaka, L.; Ettiègne- Traoré, V.; Uaheowitchai, C. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet, 2002, 360, 971-77.
69. WHO/CONRAD. Technical Consultation on Nonoxynol-9 - Summary Report. Department of Reproductive Health and Research, Family and Community Health, WHO, Geneva, 2003.
70. Xu, J.X. ; Huang, Z.R. ; Wu, Y. ; Wang, H.Y.; Zhou, X.B.; Xiao, Z.Q. Contraceptive efficacy of bioadhesive benzalkonium chloride gel in comparison with nonoxynol-9 gel. Zhonghua Fu Chan Ke Za Zhi, 2006, 41, 706-9.
71. Haineault, C.; Gourde, P.; Perron, S.; Désormeaux, A.; Piret, J.; Omar, R.F.; Tremblay, R.R.; Bergeron, M.G. Thermoreversible gel formulation containing sodium lauryl sulfate as a potential contraceptive device. Biol. Reprod., 2003, 69, 687-94.
72. Krebs, F.C.; Miller, S.R.; Malamud, D.; Howett, M.K.; Wigdahl, B. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate. Antivir. Res., 1999, 43, 157-73.
73. Gandour, R.D. Toward a design of affordable, topical microbicides: acylcarnitine analogues. Curr. Pharm. Des., 2005, 11, 3757-67.
74. Ojha, P.; Maikhuri, J.P.; Gupta, G. Effect of spermicides on Lactobacillus acidophilus in vitro - nonoxynol-9 vs. Sapindus saponins. Contraception, 2003, 68, 135-38.
75. Bélec, L.; Tévi-Bénissan, C.; Bianchi, A.; Cotigny, S.; Beumont-Mauviel, M.; Si-Mohamed, A.; Malkin, J.E. In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. J. Antimicrob. Chemother., 2000, 46, 685-93.
76. Tévi-Bénissan, C.; Makuva, M.; Morelli, A.; Georges-Courbot, M.C.; Matta, M.; Georges, A.; Bélec, L. Protection of cynomolgus macaque against cervicovaginal transmission of SIVmac251 by the spermicide benzalkonium chloride. J. Acquir. Immunol. Defic. Synder, 2000, 24, 147-53.
77. Piret, J.; Desormeaux, A.; Bergeron, M.G. Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses. Curr. Drug Targets, 2002, 3, 17-30.
78. Mauck, C.K.; Creinin, M.D.; Barnhart, K.T.; Ballagh, S.A.; Archer, D.F.; Callahan, M.M.; Schmitz, S.W.; Bax, R. A phase I comparative postcoital testing study of three concentrations of C31G. Contraception, 2004, 70, 227-31.
79. Wyrick, P.B.; Knight, S.T.; Gerbig, D.G.; Raulston, J.E.; Davis, C.H.; Paul, T.R.; Malamud, D. The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro. Antimicrob. Agents Chemother., 1997, 41, 1335-44.
80. Feldblum, P.J.; Adeiga, A.; Bakare, R.; Wevill, S.; Lendvay, A.; Obadaki, F.; Olayemi, M.O.; Wang, L.; Nanda, K.; Rountree, W. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS ONE, 2008, 23, e1474.
81. Hillier, S.L. The vaginal microbial ecosystem and resistance to HIV. AIDS Res. Hum. Retroviruses, 1998, 14, 17-21.
82. Zeitlin, L.; Hoen, T.E.; Achilles, S.L.; Hegarty, T.A.; Jerse, A.E.; Kreider, J.W.; Olmsted, S.S.; Whaley, K.J.; Cone, R.A.; Moench, T.R. Tests of buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex. Transm. Dis., 2001, 28, 417-23.
83. Mayer, K.H.; Peipert, J.; Fleming, T.; Fullem, A.; Moench, T.; Cu-Uvin, S.; Bentley, M.; Chesney, M.; Rosenberg, Z. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin. Infect. Dis., 2001, 32, 476-82.
84. Amaral, E.; Perdigão, A.; Souza, M.H.; Mauck, C.; Waller, D.; Zaneveld, L.; Faundes, A. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product. Contraception, 2006, 73, 542-7.
85. Simões J.A.; Bahamondes, L.G.; Camargo, R.P. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br. J. Clin. Pharmacol., 2006, 61, 211-7.
86. Antonio, M.A.; Hillier, S.L. DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J. Clin. Microbiol., 2003, 41, 1881-7.
87. Rao, S.; Hu, S.; McHugh, L.; Lueders, K.; Henry, K.; Zhao, Q.; Fekete, R.A.; Kar, S.; Adhya, S.; Hamer, D.H. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc. Natl. Acad. Sci. USA, 2005, 102, 11993-8.
88. Fletcher, P.S.; Harman, S.J.; Boothe, A.R.; Doncel, G.F.; Shattock, R.J. Preclinical evaluation of lime juice as a topical microbicide candidate. Retrovirology, 2008, 5, 3.
89. Schols, D.; Pauwels, R.; Desmyter, J.; De Clercq, E. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology, 1990, 175, 556-61.
90. Polydex Pharmaceuticals. USHERCELL in depth. Available at: http://www.polydex.com/v2/research/ushercell-indepth.html. [Accessed February 2009].
91. Anderson, R.A.; Feathergill, K.; Diao, X.H.; Chany, C. 2nd; Rencher, W.F.; Zaneveld, L.J.; Waller, D.P. Contraception by Ushercell (cellulose sulfate) in formulation: duration of effect and dose effectiveness. Contraception, 2004, 70, 415-22.
92. El-Sadr, W.M.; Mayer, K.H.; Maslankowski, L.; Hoesley, C.; Justman, J.; Gai, F.; Mauck, C.; Absalon, J.; Morrow, K.; Mâsse, B.; Soto-Torres, L.; Kwiecien, A. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS, 2006, 20, 1109-16.
93. Van Damme, L.; Govinden, R.; Mirembe, F.M.; Guédou, F.; Solomon, S.; Becker, M.L.; Pradeep, B.S.; Krishnan, A.K.; Alary, M.; Pande, B.; Ramjee, G.; Deese, J.; Crucitti, T.; Taylor, D.; CS Study Group. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N. Engl. J. Med., 2008, 359, 463-72.
94. Halpern, V.; Ogunsola, F.; Obunge, O.; Wang, C.H.; Onyejepu, N.; Oduyebo, O.; Taylor, D.; McNeil, L.; Mehta, N.; Umo-Otong, J.; Otusanya, S.; Crucitti, T.; Abdellati, S. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS ONE, 2008, 3, e3784.
95. Perotti, M.E.; Pirovano, A.; Phillips, D.M. Carrageenan formulation prevents macrophage trafficking from vagina: implications for microbicide development. Biol. Reprod., 2003, 69, 933-9.
96. Maguire, R.A.; Bergman, N.; Phillips, D.M. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex. Transm. Dis., 2001, 28, 259-65.
97. Van de Wijgert, J.H.; Braunstein, S.L.; Morar, N.S.; Jones, H.E.; Madurai, L.; Strickfaden, T.T.; Moodley, M.; Aboobaker, J.; Ndlovu, G.; Ferguson, T.M.; Friedland, B.A.; Hart, C.E.; Ramjee, G. Carraguard vaginal gel safety in HIV-positive women and men in South Africa. J. Acquir. Immune Defic. Syndr., 2007, 46, 538-46.
98. Kilmarx, P.H.; Van de Wijgert, J.; Chaikummao, S.; Jones, H.E.; Limpakarnjanarat, K.; Friedland, B.A.; Karon, J.M.; Manopaiboon, C.; Srivirojana, N.; Yanpaisarn, S.; Supawitkul, S.; Young, N.L.; Mock, P.A.; Blanchard, K.; Mastro, T.D. Safety and acceptability of the candidate microbicide Carraguard in Thai women: findings from a phase II clinical trial. J. Acquir. Immune Defic. Syndr., 2006, 43, 327-34.
99. Keller, M.J.; Zerhouni-Layachi, B.; Cheshenko, N.; John, M.; Hogarty, K.; Kasowitz, A.; Goldberg, C.L.; Wallenstein, S.; Profy, A.T.; Klotman, M.E.; Herold, B.C. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo controlled trial. J. Infect. Dis., 2006, 193, 27-35.
100. Van Damme, L.; Wright, A.; Depraetere, K.; Rosenstein, I.; Vandersmissen, V.; Poulter, L.; McKinlay, M.; Van Dyck, E.; Weber, J.; Profy, A.; Laga, M.; Kitchen, V. A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Sex. Transm. Infect., 2000, 76, 126-30.
101. Joshi, S.; Dutta, S.; Bell, B.; Profy, A.; Kuruc, J.; Fang, G.; Cianciola, M.; Maslankowski, L.; Soto-Torres, L.; Panchanadikar, A.; Mehendale, S.; Reynolds, S.J. Documenting intermenstrual bleeding in a vaginal microbicide study: case reports and lessons learned. AIDS Res. Hum. Retroviruses, 2006, 22, 294-6.
102. Lu, H.; Zhao, Q.; Wallace, G.; Liu, S.; He, Y.; Shattock, R.; Neurath, A.R.; Jiang, B.S. Cellulose acetate 1,2-benzenedicarboxylate inhibits infection by cell-free and cellassociated primary HIV-1 isolates. AIDS Res. Hum. Retroviruses, 2006, 22, 411-8.
103. Fichorova, R.N.; Zhou, F.; Ratnam, V.; Atanassova, V.; Jiang, S.; Strick, N.; Neurath, A.R. Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation. Antimicrob. Agents Chemother., 2005, 49, 323-35.
104. Wilson, L.A.; Murphey-Corb, M.; Martin, L.N.; Harrison, R.M.; Ratterree, M.S.; Bohm, R.P. Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta). J. Med. Primatol., 2000, 29, 173-81.
105. Alkhatib, G.; Combadiere, C.; Broder, C.C.; Feng, Y.; Kennedy, P.E.; Murphy, P,M.; Berger, E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophagetropic HIV-1. Science, 1996, 272, 1955-8.
106. McDermott, D.H.; Zimmerman, P.A.; Guignard, F.; Kleeberger, C.A.; Leitman, S.F.; Murphy, P.M. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet, 1998, 352, 866-70.
107. Lederman, M.M.; Veazey, R.S.; Offord, R.; Mosier, D.E.; Dufour, J.; Mefford, M.; Piatak, M. Jr.; Lifson, J.D.; Salkowitz, J.R.; Rodriguez, B.; Blauvelt, A.; Hartley, O. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science, 2004, 306, 485-7.
108. Torre, V.S.; Marozsan, A.J.; Albright, J.L.; Collins, K.R.; Hartley, O.; Offord, R.E.; Quiñones-Mateu, M.E.; Arts, E.J. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs. J. Virol., 2000, 74, 4868-76.
109. Kawamura, T.; Bruse, S.E.; Abraha, A.; Sugaya, M.; Hartley, O.; Offord, R.E.; Arts, E.J.; Zimmerman, P.A.; Blauvelt, A. PSCRANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. J. Virol., 2004, 78, 7602-9.
110. Balzarini, J.; Van Laethem, K.; Hatse, S.; Froeyen, M.; Peumans, W.; Van Damme, E.; Schols, D. Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV gp120: a new therapeutic concept to hit the achilles heel of HIV. J. Biol. Chem., 2005, 280, 41005-14.
111. Tsai, C.C.; Emau, P.; Jiang, Y.; Tian, B.; Morton, W.R.; Gustafson, K.R.; Boyd, M.R. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retroviruses, 2003, 19, 535-41.
112. Tsai, C.C.; Emau, P.; Jiang, Y.; Agy, M.B.; Shattock, R.J.; Schmidt, A.; Morton, W.R.; Gustafson, K.R.; Boyd, M.R. Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res. Hum. Retroviruses, 2004, 20, 11-18.
113. Pusch, O.; Boden, D.; Hannify, S.; Lee, F.; Tucker, L.D.; Boyd, M.R.; Wells, J.M.; Ramratnam, B. Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin. J. Acquir. Immune Defic. Syndr., 2005, 40, 512-20.
114. Balzarini, J.; Zhang, H.; Herdewijn, P.; Johns, D.; De Clercq, E. Intracellular metabolism and mechanism of antiretrovirus action of immunodeficiency virus compound. Proc. Natl. Acad. Sci. USA, 1991, 88, 1499-503.
115. Fletcher, P.S.; Elliott, J.; Grivel, J.C.; Margolis, L.; Anton, P.; McGowan, I.; Shattock, R.J. Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides. AIDS, 2006, 20, 1237-45.
116. Di Fabio, S.; Van Roey, J.; Giannini, G.; van den Mooter, G.; Spada, M.; Binelli, A.; Pirillo, M.F.; Germinario, E.; Belardelli, F.; de Bethune, M.P.; Vella, S. Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. AIDS, 2003, 17, 1597-604.
117. Malcolm, R.K.; Woolfson, A.D.; Toner, C.F.; Morrow, R.J.; McCullagh, S.D. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. J. Antimicrob. Chemother., 2005, 56, 954-6.
118. Zussman, A.; Lara, L.; Lara, H.H.; Bentwich, Z.; Borkow, G. Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781. AIDS, 2003, 17, 653-61.
119. Fletcher, P.; Kiselyeva, Y.; Wallace, G.; Romano, J.; Griffin, G.; Margolis, L.; Shattock, R. The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells. J. Virol., 2005, 79, 11179-86.
120. Schwartz, J.L.; Kovalevsky, G.; Lai, J.J.; Ballagh, S.A.; McCormick, T.; Douville, K.; Mauck, C.K.; Callahan, M.M. A randomized six day safety study of an antiretroviral microbicide candidate UC-781, a non-nucleoside reverse transcriptase inhibitor. Sex. Transm. Dis., 2008, 35, 414-19.
121. Liu, S.; Lu, H.; Neurath, A.R.; Jiang, S. Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection. Antimicrob. Agents Chemother., 2005, 49, 1830-6.
122. Ndesendo, V.M.; Pillay, V.; Choonara, Y.E.; Buchmann, E.; Bayever, D.N.; Meyer, L.C. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS Pharm-SciTech., 2008, 9, 505-20.
123. Lackman-Smith, C.; Osterling, C.; Luckenbaugh, K.; Mankowski, M.; Snyder, B.; Lewis, G.; Paull, J.; Profy, A.; Ptak. R.G.; Buckheit, R.W. Jr.; Watson, K.M.; Cummins, J.E. Jr.; Sanders-Beer, B.E. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob. Agents Chemother., 2008, 52, 1768-81.
124. Veazey, R.S; Klasse, P.J; Schader, S.M; Hu, Q.; Ketas, T.J.; Lu, M.; Marx, P.A.; Dufour, J.; Colonno, R.J.; Shattock, R.J.; Springer, M.S.; Moore, J.P. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature, 2005, 438, 99-102.
125. Neurath, A.R.; Strick, N.; Li, Y.Y. Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. BMC Infect. Dis., 2006, 6, 150.
126. Vieira, O.V.; Hartmann, D.O.; Cardoso, C.M.; Oberdoerfer, D.; Baptista, M.; Santos, M.A.; Almeida, L.; Ramalho-Santos, J.; Vaz, W.L. Surfactants as microbicides and contraceptive agents: a systematic in vitro study. PLoS ONE, 2008, 3, e2913.